Courses from SDA Bocconi School of Management:
- Full-Time MBA
- Master in Corporate Finance
- Master in Fasion, Experience & Design Management
- Master of International Health Care Management Economics and Policy
- Master of Management in Food & Beverage
- Master of Public Management

SDA Bocconi School of Management
Full-Time, Part-Time
Master Program: Master of International Health Care Management Economics and Policy
Learning purpose
A fully international perspective through its contents, faculty members and students. A thorough knowledge of the political, economic and social context in which health care systems operate around the world.
As a participant, you will spend full-time 12 months in acquiring the specific skills needed to take on management roles in the private industry (pharmaceutical, medical device and biotech companies), government and international organizations, and health care providers.
Whilst expanding the horizons of your health career, you will obtain solid theoretical and practical bases to successfully manage organizational and policy changes in health care systems around the globe.
Programme
Rapid changes in healthcare systems require new professionals with a deep understanding of health and healthcare issues and a wide spectrum of skills to promote and manage changes at the organizational and policy level.
MIHMEP intends to train a new cadre of professionals by providing an interdisciplinary and international program specifically focused on healthcare management and policy.
Through an itinerary comprising 9 months of classroom activities and a 3 month field project, participants will develop theoretical and practical skills in management, economic analysis, policy analysis and formulation, and epidemiology.
The program is designed to ensure that participants:
- fully comprehend and learn to lead the important new developments occurring in health-related industries (pharmaceutical, biotech, medical device companies);
- achieve substantial skills and competencies in the management of healthcare organizations;
- gain experience in applying qualitative and quantitative methods to promote and manage change at the organizational and policy level;
- understand the epidemiological factors and the political, economic and social context of healthcare management from an international perspective;
- understand the political process and strategy which drive the international health arena
The challenging learning experience is enriched with intensive cultural exchange between participants coming from variety of backgrounds and from different parts of the world.
Program Structure
CORE COURSES
First Term September - December 2012
* Epidemiology
* Health Care Systems & Policy
* Health Economics
* Foundations of Management
* Quantitative Methods
Second Term Jenuary 2013 - March 2013
* Economic Evaluation of Health Care Programs
* Issues in Public Health
* Financial Accounting
SPECIALIZATION
Third Term April - May 2013
At MIHMEP 14 (academic year 2012-2013) students will be expected to choose 1 among 3 Specializations. There will be a total number of 120 hours of Specialization courses and seminars to be taken by every MIHMEP student in the 3rd term (certain courses may also be delivered in the 2nd term).
Choosing a Specialization is mandatory.
The Specializations in the academic year 2012-2013 are the following:
* Global Health & Development
* Health Care Management
* Pharmaceutical & Medical Technology
In addition to the chosen Specialization, to receive the MIHMEP Diploma students have to choose 2 more courses (minimum 48 hours) from the offer of the other MIHMEP Specializations. The choice of these additional courses can be based on the individual's interests and future career expectations, adding value to the Specialization courses by learning new subjects.
After the completion of MIHMEP, students will be awarded the MIHMEP Diploma and a separate certificate reporting the Specialization undertaken. It could be used on the market to reinforce one's ability to be selected for a position should one need to use it as a proof of additional/specific qualification. However the MIHMEP diploma itself would not prevent a student from applying for a position and receiving a job not related to a chosen Specialization.
Evaluation
Students’ performance in each course will be evaluated on the basis of final exam, group work and class participation.
INTERNSHIP June - September 2013
Projects
During the fourth term, students participate in an internship within a healthcare organization or a company in Italy or abroad. The projects are carried out over a period of 12 weeks and require full-time commitment. During the internship, students are supervised by two tutors: one from the host organization and the other from the MIHMEP Faculty. Near the end of the first term, the Internship Day is organized in order for MIHMEP students to meet field project providers and to present internship options.
Providers
Internships may be performed in pharmaceutical/medical device companies, national and regional health authorities, hospitals, health insurance organizations, NGOs, supranational organizations, research centres and consulting companies. All represent potential employing organizations for MIHMEP students. At the end of the program, students will receive advice concerning job placement and the best job options available both in Italy and abroad.
Evaluation
At the end of the experience the students prepare a report describing and discussing the results of their projects
Entry Requirements
Admissions Requirements
University Degree in any discipline
Fluency in English (TOEFL or similar)
GMAT/GRE
Work experience (not essential)
Professional perspective and employment market
Through the program participants develop theoretical and practical skills in health and healthcare management, economic analysis, policy analysis and formulation, and epidemiology.
MIHMEP graduates have gone on to rewarding careers in many healthcare fields. The main recruiting companies are public and private health care organizations, consulting firms, private companies, companies from the bio-pharmaceutical and medical device sectors, University and research centres, Ministry of Health and international organizations.

